Kai Fu Selected Research

Kai Fu Research Topics

Disease

65	Neoplasms (Cancer) 03/2024 - 04/2002
21	Lymphoma (Lymphomas) 01/2023 - 06/2005
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2019 - 06/2006
15	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 06/2005
14	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 12/2005
12	Carcinogenesis 01/2022 - 11/2010
10	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2017
8	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 01/2020
8	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2018
6	Infections 02/2023 - 03/2012
6	Lung Neoplasms (Lung Cancer) 05/2020 - 04/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 03/2008
5	Inflammation (Inflammations) 01/2023 - 07/2008
5	Wounds and Injuries (Trauma) 11/2022 - 01/2014
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2010
5	Leukemia 01/2021 - 07/2013
5	Fibrosis (Cirrhosis) 01/2020 - 04/2008
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 08/2011
4	Disease Progression 01/2021 - 01/2012
4	Pain (Aches) 01/2018 - 04/2014
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 11/2014
4	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2015 - 06/2006
3	Adenocarcinoma of Lung 01/2024 - 04/2008
3	Glioma (Gliomas) 04/2023 - 02/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2015
3	Wilms Tumor (Wilm's Tumor) 01/2021 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 06/2013
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 04/2015
3	Contact Dermatitis (Eczema, Contact) 01/2017 - 04/2014
3	Autoimmune Diseases (Autoimmune Disease) 03/2016 - 01/2013
2	Sepsis (Septicemia) 03/2024 - 09/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 01/2023
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 12/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 08/2010
2	Hypospadias 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
2	Adenoma (Adenomas) 11/2021 - 12/2014
2	Critical Illness (Critically Ill) 05/2021 - 01/2020
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 01/2011
2	Hyperplasia 01/2021 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 04/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
12	Messenger RNA (mRNA)IBA 01/2024 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 09/2023 - 03/2014
10	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
8	Circular RNAIBA 01/2021 - 09/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2005
7	CyclinsIBA 01/2019 - 12/2005
7	Rituximab (Mabthera)FDA Link 01/2017 - 10/2008
6	Cyclin D1IBA 01/2023 - 12/2005
5	Transcription Factors (Transcription Factor)IBA 01/2024 - 03/2008
5	Phosphotransferases (Kinase)IBA 01/2019 - 04/2008
4	RNA (Ribonucleic Acid)IBA 11/2023 - 02/2013
4	ParaffinIBA 05/2017 - 05/2012
4	AntibodiesIBA 11/2014 - 04/2002
3	Gemcitabine FDA Link 03/2024 - 01/2012
3	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 04/2008
3	Fluorouracil (Carac)FDA LinkGeneric 03/2023 - 01/2020
3	Competitive Endogenous RNAIBA 01/2023 - 01/2019
3	ChromatinIBA 01/2023 - 10/2009
3	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2014
3	IgKIBA 01/2021 - 08/2006
3	AntigensIBA 01/2021 - 12/2012
3	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 11/2010
3	Cyclin D2IBA 10/2018 - 12/2005
3	Therapeutic UsesIBA 01/2018 - 06/2015
3	Formaldehyde (Formol)FDA Link 05/2017 - 05/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 11/2008
3	squaric acidIBA 01/2017 - 09/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2013 - 11/2008
2	LipidsIBA 04/2024 - 03/2019
2	Interleukin-6 (Interleukin 6)IBA 03/2024 - 10/2023
2	CateninsIBA 01/2024 - 11/2021
2	Histones (Histone)IBA 12/2023 - 10/2012
2	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2018
2	anandamide (arachidonylethanolamide)IBA 04/2023 - 02/2016
2	MutagensIBA 02/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2017
2	venetoclaxIBA 01/2023 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2012
2	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 11/2017
2	Type III Secretion SystemsIBA 01/2022 - 03/2015
2	Long Noncoding RNAIBA 06/2021 - 01/2020
2	Calcibiotic Root Canal SealerIBA 01/2021 - 12/2014
2	Piwi-Interacting RNAIBA 11/2019 - 01/2019
2	B7-H1 AntigenIBA 08/2019 - 05/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 09/2010
2	TensinsIBA 01/2019 - 09/2010

Therapy/Procedure

28	Therapeutics 04/2024 - 12/2004
20	Drug Therapy (Chemotherapy) 03/2024 - 06/2006
5	Immunotherapy 03/2024 - 01/2018
3	Deep Brain Stimulation 01/2022 - 11/2017
2	Radiotherapy 03/2024 - 07/2013
2	Aftercare (After-Treatment) 09/2021 - 05/2017
2	Artificial Respiration (Mechanical Ventilation) 05/2021 - 12/2017
2	Enteral Nutrition (Feeding, Tube) 01/2020 - 12/2017
2	Lasers (Laser) 01/2020 - 01/2020